Skip to main content
TipRanks
Go Ultimate75% OFF

KUSURI NO AOKI HOLDINGS CO.,LTD. (3549) AI Stock Analysis

0 Followers
JP:3549

KUSURI NO AOKI HOLDINGS CO.,LTD.

(TSE/TYO:3549)

Select Model
Rating:56Neutral
Price Target:JPY 5,225.00â–²(3.00% Upside)
Action:reiterated
Date:10/03/26

The score is held back primarily by financial performance: a sharp 2026 revenue decline, higher leverage, and volatile free cash flow outweigh the otherwise steady profitability and positive operating cash flow. Technicals are moderately supportive with the stock above key moving averages, but negative MACD and a higher RSI temper the trend. Valuation is middling (P/E ~22) with a low dividend yield, providing limited cushion.

Positive Factors
Multi-year Revenue ExpansionStrong revenue expansion through 2025 indicates that the drugstore network and its mix of pharmaceuticals, OTC medicines, health and beauty products, and daily necessities were gaining commercial traction. This scale and category breadth can support continued customer reach and operating leverage over the coming quarters.
Negative Factors
2026 Revenue ContractionThe 11.6% revenue decline in 2026 interrupts the strong growth pattern of the prior three years and signals weaker recent demand or store productivity. Slightly lower net income reinforces the concern that the slowdown is affecting earnings, potentially limiting reinvestment and reducing near-term operating momentum.

KUSURI NO AOKI HOLDINGS CO.,LTD. (3549) vs. iShares MSCI Japan ETF (EWJ)

-20%-10%0%10%20%30%40%JP:3549+33.15%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 481.75B
Dividend Yield
0.29%
Average Volume (3M)
300.76K
Price to Earnings (P/E)
26.3
Beta (1Y)
0.33
Revenue Growth
12.54%
EPS Growth
15.87%
Country
Japan
Employees
6,355
Sector
Healthcare
Sector Strength
51
Industry
Medical - Pharmaceuticals

KUSURI NO AOKI HOLDINGS CO.,LTD. Business Overview & Revenue Model

Company Description

Founded in 1999 and headquartered in Hakusan, Japan, Kusuri No Aoki Holdings Co., Ltd. primarily engages in the sale and dispensing of medications, cosmetics, and various everyday consumer products across Japan.

How the Company Makes Money

The company makes money primarily through retail sales generated at its drugstore locations. Revenue is earned from the sale of (1) prescription-related products and services (e.g., dispensing associated with pharmacies) and (2) front-of-store mercha...

KUSURI NO AOKI HOLDINGS CO.,LTD. Financial Statement Overview

Summary

Income statement is solid but cooling: strong multi-year revenue growth was followed by a notable 2026 revenue decline (-11.6%) and slightly lower net income vs 2025. Balance sheet risk increased as debt rose materially in 2026, reducing flexibility. Operating cash flow is positive and improved in 2026, but free cash flow has been volatile and relatively modest recently, weakening overall cash quality.

Income Statement

62Positive

Balance Sheet

56Neutral

Cash Flow

48Neutral
Financial statement breakdown
BreakdownTTMMay 2025May 2024May 2023May 2022May 2021
Income Statement
Total Revenue586.17B566.87B501.47B436.88B378.87B328.33B
Gross Profit139.66B135.03B120.47B106.29B94.64B80.98B
EBITDA45.60B42.87B39.18B32.00B28.74B23.76B
Net Income18.97B17.13B17.79B12.31B12.33B9.84B
Balance Sheet
Total Assets406.45B410.94B352.46B303.45B276.33B236.08B
Cash, Cash Equivalents and Short-Term Investments58.99B58.93B47.73B49.13B42.87B26.35B
Total Debt143.57B149.77B99.32B98.78B89.50B78.13B
Total Liabilities261.41B269.90B206.70B186.03B177.78B149.14B
Stockholders Equity145.04B141.04B145.76B117.42B98.55B86.93B
Cash Flow
Free Cash Flow03.84B448.00M7.20B10.84B-6.26B
Operating Cash Flow037.32B22.17B26.86B31.25B20.29B
Investing Cash Flow0-42.88B-31.08B-21.10B-22.26B-27.77B
Financing Cash Flow016.49B7.67B344.00M7.53B18.10B

KUSURI NO AOKI HOLDINGS CO.,LTD. Technical Analysis

Technical Analysis SentimentPositive
Last Price5073.00

Price Trends

50DMA4271.04Positive
100DMA4074.27Positive
200DMA3947.45Positive

Market Momentum

MACD245.59Negative
RSI68.02Neutral
STOCH92.46Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3549, the sentiment is Positive. The current price of 5073.00 is above the 20-day moving average (MA) of 4583.95, above the 50-day MA of 4271.04, and above the 200-day MA of 3947.45, indicating a bullish trend. The MACD of 245.59 indicates Negative momentum. The RSI at 68.02 is Neutral, neither overbought nor oversold. The STOCH value of 92.46 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3549.

KUSURI NO AOKI HOLDINGS CO.,LTD. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:3549 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:3391JP:339181OutperformJPY 1.13T20.317.13%1.88%――
JP:3148JP:314870OutperformJPY 207.99B12.89―2.83%8.67%3.24%
JP:7649JP:764969NeutralJPY 550.50B17.889.94%1.24%8.97%-29.54%
JP:9989JP:998969NeutralJPY 458.81B15.6511.04%3.36%3.99%-0.48%
JP:3349JP:334960NeutralJPY 512.38B16.29―1.27%8.99%3.61%
JP:3549JP:354956NeutralJPY 485.06B26.29―0.29%12.54%15.87%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-20%0%20%JP:3549JP:9989JP:7649JP:3391JP:3148JP:3349Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:3549 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:3549KUSURI NO AOKI HOLDINGS CO.,LTD.5073.001236.3532.22%
JP:9989Sundrug Co 3924.00-187.45-4.56%
JP:7649Sugi Holdings Co 1416.50-292.70-17.12%
JP:3391TSURUHA Holdings 2500.00-202.22-7.48%
JP:3148Create SD Holdings Co., Ltd.3290.00167.315.36%
JP:3349COSMOS Pharmaceutical Corporation6437.00-929.03-12.61%

KUSURI NO AOKI HOLDINGS CO.,LTD. Corporate Events

Kusuri No Aoki Reports Treasury-Share Purchases

Nov 12, 2026

KUSURI NO AOKI HOLDINGS CO., LTD. announced that it purchased 51,400 common shares for ¥223,680,500 through market transactions on the Tokyo Stock Exchange between October 1 and October 31, 2026.The purchases were conducted under a board resolution d...

Kusuri No Aoki Reports October Sales and 15 New Outlets

Nov 5, 2026

KUSURI NO AOKI HOLDINGS CO., LTD. operates drugstores, dispensing pharmacies and supermarkets, with a regional retail focus across Japan.For October 2026, covering September 21 to October 20, all-store sales were reported at 111.5%, while existing-st...

Kusuri No Aoki Discloses No Share Buybacks Yet Under Ongoing Authorization

Oct 5, 2026

Kusuri No Aoki Holdings Co., Ltd. reported the status of its ongoing share buyback program authorized by a December 25, 2025 board resolution, which permits the repurchase of up to 6 million shares, or 6.32% of outstanding stock, for a maximum of 24...

Kusuri no Aoki posts robust September sales and accelerates store expansion

Oct 1, 2026

Kusuri no Aoki Holdings reported strong September sales for the fiscal year ending May 2027, with all-store sales up 12.8% year on year and existing-store sales rising 2.4%, driven by higher customer traffic and increased average spending per custome...

Kusuri no Aoki posts robust Q1 earnings and keeps strong full-year forecast

Oct 1, 2026

Kusuri no Aoki Holdings reported strong first-quarter results for the three months to August 20, 2026, with net sales up 13.8% to ¥159.0 billion and operating profit rising 16.0% to ¥8.4 billion. Profit attributable to owners of the parent jumped 36....

Kusuri No Aoki Reports No Activity in Ongoing Share Buyback Program

Sep 4, 2026

Kusuri No Aoki Holdings Co., Ltd. is a Japanese drugstore and retail pharmacy operator, selling pharmaceuticals and daily consumer goods through a chain-store model. The company is listed on the Tokyo Stock Exchange Standard and Nagoya Stock Exchange...

Kusuri no Aoki Posts Strong August Sales and Expands Store Network Nationwide

Sep 4, 2026

Kusuri no Aoki Holdings reported solid performance for August 2026, with all-store sales rising 10.7% year on year and existing-store sales up 0.7%, driven by higher customer traffic and steady gains in average spending per customer. The figures, bas...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 03, 2026